Figure 1
From: Missing ligand model in autologous stem cell transplantation
Disease-free survival (upper panel) and cumulative incidence of relapse (lower panel) are not different between patients with or without a missing KIR ligand after high-dose chemotherapy and autologous haematopoietic stem cell transplantation.
